<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE LIFECORE BIOMEDICAL, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED DECEMBER 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000028626 <NAME> LIFECORE BIOMEDICAL, INC. <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> JUN-30-2000 <PERIOD-START> JUL-01-1999 <PERIOD-END> DEC-31-1999 <CASH> 1,409,000 <SECURITIES> 0 <RECEIVABLES> 6,046,000 <ALLOWANCES> 393,000 <INVENTORY> 24,671,000 <CURRENT-ASSETS> 23,487,000 <PP&E> 42,159,000 <DEPRECIATION> 10,791,000 <TOTAL-ASSETS> 70,798,000 <CURRENT-LIABILITIES> 8,044,000 <BONDS> 6,649,000 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 124,000 <OTHER-SE> 55,479,000 <TOTAL-LIABILITY-AND-EQUITY> 70,798,000 <SALES> 15,667,000 <TOTAL-REVENUES> 15,667,000 <CGS> 6,879,000 <TOTAL-COSTS> 14,702,000 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 466,000 <INCOME-PRETAX> 502,000 <INCOME-TAX> 0 <INCOME-CONTINUING> 502,000 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 502,000 <EPS-BASIC> .04 <EPS-DILUTED> .04